| Dr Ladonna Mae Johnson, DO | |
|
201 Plageman Bldg, Oregon State University - Student Health, Corvallis, OR 97331-5801 | |
| (541) 737-3106 | |
| (541) 737-4530 |
| Full Name | Dr Ladonna Mae Johnson |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 201 Plageman Bldg, Corvallis, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124103445 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | DO19146 (Oregon) | Primary |
| 207Q00000X | Family Medicine | 20A5511 (California) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ladonna Mae Johnson, DO 201 Plageman Bldg, Oregon State University - Student Health, Corvallis, OR 97331-5801 Ph: (541) 737-3106 | Dr Ladonna Mae Johnson, DO 201 Plageman Bldg, Oregon State University - Student Health, Corvallis, OR 97331-5801 Ph: (541) 737-3106 |
News Archive
A new study of the records of millions of nursing home residents affirms the value of influenza vaccination among the elderly. The Brown University analysis found that between 2000 and 2009, the better matched the vaccine was for the influenza strain going around, the fewer nursing home residents died or were hospitalized.
In response to the pandemic, Ecolab, the global leader in water, food safety and infection prevention solutions and services, has increased its production capacity seven fold in Europe to provide customers with critical hand sanitizer and surface disinfectant solutions to help prevent the spread of SARS-CoV-2, the virus that causes COVID-19.
Neural precursor cells (NPC) in the young brain suppress certain brain tumors such as high-grade gliomas, especially glioblastoma (GBM), which are among the most common and most aggressive tumors.
Elan Drug Technologies, a business unit of Elan Corporation, plc (NYSE: ELN) today issued the following statement regarding the U.S. Food and Drug Administration (FDA) approval of AMPYRA™ (dalfampridine) as a treatment to improve walking in patients with multiple sclerosis (MS).
› Verified 6 days ago
Dr. Ashkan Abedini, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-4906 | |
Dr. Nicole Keyser, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-4906 | |
Aaron Wang, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-4906 | |
Dolly Nicole Myers, D.O Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-4906 | |
Bryce L Cleary, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3680 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-754-1150 | |
Jennifer L Micek, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 530 Nw 27th St, Corvallis, OR 97330 Phone: 541-766-6835 Fax: 541-766-6186 | |
Tobin D Rummel, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1760 Sw 3rd St, Corvallis, OR 97333 Phone: 541-207-3773 Fax: 800-549-1017 |